C. Tang

发表

Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysis

Careen K. Tang, Hong Ge, X. Gong, 2002, International journal of cancer.

Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance

C. Yen, P. Lu, Jang-Yang Chang, 2013, Journal of Biomedical Science.

Tumor progression and metastasis from genetic to microenvironmental determinants

S. Sheng, S. Batra, L. Coussens, 2006, Cancer biology & therapy.

Induction of sensitivity to doxorubin and etoposide by transfection of MCF-7 breast cancer cells with here β-2

R. Lupu, Dajun Yang, L. Harris, 1998 .

Cripto-1 Indirectly Stimulates the Tyrosine Phosphorylation oferb B-4 through a Novel Receptor*

A. Ebert, C. Bianco, D. Salomon, 1999, The Journal of Biological Chemistry.

Metastasis in Breast Cancer Cells in Vivo Invasiveness and in Vitro Suppresses KAI 1 Overexpression of Updated Version

Careen K. Tang, M. Lippman, R. Slack, 2001 .

Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB 2 and ErbB 3 receptors and ErbB

P. Fedi, Careen K. Tang, M. Frankel, 2013 .

ErbB-4 Ribozymes Abolish Neuregulin-induced Mitogenesis 1

Jennifer, Jacalyn, H. Pierce, 2006 .

Study the Pathogenic Role of ErbB-3, ErbB-4 and their Ligand Heregulin in Human Breast Cancer Cells.

C. Tang, 2000 .

CXCR4 suppression attenuates EGFRvIII-mediated invasion and induces p38 MAPK-dependent protein trafficking and degradation of EGFRvIII in breast cancer cells.

Careen K. Tang, Theodore A. Toth, Massod Rahimi, 2011, Cancer letters.

EGFR variant‐mediated invasion by enhanced CXCR4 expression through transcriptional and post‐translational mechanisms

Careen K. Tang, Jessica A George, Massod Rahimi, 2010, International journal of cancer.

EGFRvIII‐induced estrogen‐independence, tamoxifen‐resistance phenotype correlates with PgR expression and modulation of apoptotic molecules in breast cancer

Yang Zhang, Hua Su, Massod Rahimi, 2009, International journal of cancer.

Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.

Careen K. Tang, M. Lippman, A. Wong, 2000, Cancer research.

Suppression of EGFRvIII‐mediated proliferation and tumorigenesis of breast cancer cells by ribozyme

Careen K. Tang, Xunyi Luo, X. Gong, 2003, International journal of cancer.

Anticorps monoclonaux specifiques d'egfrviii, ribozymes d'egfrviii et utilisations en detection, traitement ou prevention de cancer associe a l'egfrviii

C. Tang, 2003 .

Ribozyme Targeting the Novel Fusion Junction of EGFRvIII in Breast Cancer

C. Tang, 2003 .

A Novel Molecular Targeting of a Tumor-Specific Oncogenic Mutant Receptor in Human Prostate Cancer

C. Tang, 2005 .

EGF Family Receptors and Their Ligands in Human Cancer

Careen K. Tang, M. Lippman, C. Tang, 1998 .

AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.

J. Mestan, D. Fabbro, H. Lane, 2004, Cancer research.

Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer

R. Lupu, Careen K. Tang, M. Tsai, 2003, Oncogene.

Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesis

J. Sarkaria, T. Fenton, W. Cavenee, 2012, Proceedings of the National Academy of Sciences.

Advances in Brief KAI 1 Protein Is Down-Regulated during the Progression of Human Breast Cancer 1

M. Lippman, R. Slack, L. Wei, 2000 .

Epidermal growth factor and betacellulin mediate signal transduction through co‐expressed ErbB2 and ErbB3 receptors

P. Fedi, Careen K. Tang, Ling-mei Wang, 1997, The EMBO journal.

3,3'-Diindolylmethane (DIM) inhibits the growth and invasion of drug-resistant human cancer cells expressing EGFR mutants.

Careen K. Tang, Kai Huang, Massod Rahimi, 2010, Cancer letters.

Co-expression of EGFRvIII with ErbB-2 enhances tumorigenesis: EGFRvIII mediated constitutively activated and sustained signaling pathways, whereas EGF-induced a transient effect on EGFR-mediated signaling pathways

Baljit Singh, Careen K. Tang, Hong Yu, 2008, Cancer biology & therapy.

Unusual mRNA pseudoknot structure is recognized by a protein translational repressor

D. Draper, Careen K. Tang, C. Tang, 1989, Cell.

TOB suppresses breast cancer tumorigenesis

Tao Zhang, Hua Su, Careen K. Tang, 2009, International journal of cancer.

AEE788

J. Mestan, D. Fabbro, H. Lane, 2004, Cancer Research.

18 - Role of Epidermal Growth Factor Receptor in Breast Carcinoma

Careen K. Tang, C. Tang, 2002 .

Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo.

R. Lupu, Careen K. Tang, E. Atlas, 2003, Molecular cancer research : MCR.

Involvement of Heregulin-β2 in the Acquisition of the Hormone-independent Phenotype of Breast Cancer Cells

R. Lupu, Careen K. Tang, T. Grunt, 1996 .

Hypophosphorylation of residue Y1045 leads to defective downregulation of EGFRvIII

Careen K. Tang, Hong Yu, W. Han, 2006, Cancer biology & therapy.

Chemokine receptor CXCR4-mediated transformation of mammary epithelial cells by enhancing multiple RTKs expression and deregulation of the p53/MDM2 axis.

Hua Su, S. Lelièvre, Careen K. Tang, 2011, Cancer letters.